Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Unrecognised Comorbidity Detection in Hospitalised Patients

Active, not recruiting

Conditions: Diabetes
Atrial Fibrillation (AF)
Cardiac Disease

First Posted Date: 2025-03-18

Last Posted Date: 2025-03-18

Lead Sponsor: University of Oxford

Target Recruit Count: 4500000

Registration Number: NCT06881797

Locations: 🇬🇧
Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Investigating the Effects of Transcranial Stimulation to Advance Stroke Rehabilitation

Not Applicable

Recruiting

Conditions: Stroke
Upper Limb Function

First Posted Date: 2025-02-24

Last Posted Date: 2025-03-07

Lead Sponsor: University of Oxford

Target Recruit Count: 60

Registration Number: NCT06842095

Locations: 🇬🇧
Oxford Centre for Functional MRI of the Brain (FMRIB), Oxford, United Kingdom

Kinshasa Lung Ultrasound Approach Validation

Recruiting

Conditions: Respiratory Disease
Children, Only

First Posted Date: 2025-02-21

Last Posted Date: 2025-02-21

Lead Sponsor: University of Oxford

Target Recruit Count: 178

Registration Number: NCT06839963

Locations: 🇧🇩
Chittagong Medical College Hospital, Chittagong, Bangladesh
🇨🇩
Kinshasa School of Public Health, University of Kinshasa, Kinshasa, Congo, The Democratic Republic of the
🇸🇱
Pujehun Govt Hospital Medical, Pujehun, Sierra Leone

Surveillance of AMR in DRC

Recruiting

Conditions: Bacteremia

First Posted Date: 2025-02-11

Last Posted Date: 2025-02-20

Lead Sponsor: University of Oxford

Target Recruit Count: 210

Registration Number: NCT06821282

Locations: 🇨🇩
Kinshasa, Democratic Republic of Congo, Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the

Capillary OGTT Study

Recruiting

Conditions: Type 1 Diabetes (T1D)

First Posted Date: 2025-02-07

Last Posted Date: 2025-02-07

Lead Sponsor: University of Oxford

Target Recruit Count: 90

Registration Number: NCT06815081

Locations: 🇬🇧
Noah's Ark Childrens Hospital for Wales, Cardiff, United Kingdom
🇬🇧
Royal London Barts Health NHS Trust, London, United Kingdom
🇬🇧
Nottingham Childrens Hospital, Nottingham, United Kingdom

and more 1 locations

Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

Phase 2

Not yet recruiting

Conditions: Rift Valley Fever

Interventions: Biological: ChAdOx1 RVF
Biological: Rabies Vaccine

First Posted Date: 2025-01-29

Last Posted Date: 2025-07-02

Lead Sponsor: University of Oxford

Target Recruit Count: 240

Registration Number: NCT06799234

Locations: 🇰🇪
KEMRI-Wellcome Trust Research Programme, Kilifi, Coast, Kenya

Stratification and Treatment in Early Psychosis Study - ENHANCE

Phase 3

Not yet recruiting

Conditions: Psychosis
Psychotic Disorders
Psychotic Episode
First Episode Psychosis

Interventions: Drug: CBD 100 mg/mL Oral Solution
Other: Placebo

First Posted Date: 2025-01-16

Last Posted Date: 2025-01-16

Lead Sponsor: University of Oxford

Target Recruit Count: 250

Registration Number: NCT06778564

Locations: 🇦🇹
MedUni Vienna, Vienna, Austria
🇩🇪
University of Augsburg, Augsburg, Germany
🇩🇪
Charité Universitätsmedizin, Berlin, Germany

and more 14 locations

Carriage to Assess Protection of New Pneumococcal Vaccines - PCV15

Phase 4

Recruiting

Conditions: Pneumococcal Disease
Pneumococcal Carriage

Interventions: Biological: PCV15
Biological: Streptococcus pneumoniae serotype 3
Biological: Placebo

First Posted Date: 2024-12-12

Last Posted Date: 2025-04-15

Lead Sponsor: University of Oxford

Target Recruit Count: 106

Registration Number: NCT06731374

Locations: 🇬🇧
Liverpool Vaccine Group, Liverpool, North West, United Kingdom
🇬🇧
Oxford Vaccine Group, Oxford, Oxfordshire, United Kingdom

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

Phase 1

Recruiting

Conditions: Menopause
Metabolic Dysfunction Associated Steatotic Liver Disease

Interventions: Drug: Menopausal hormone therapy

First Posted Date: 2024-11-26

Last Posted Date: 2025-01-13

Lead Sponsor: University of Oxford

Target Recruit Count: 10

Registration Number: NCT06704516

Locations: 🇬🇧
Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford, Oxfordshire, United Kingdom

Effort and Antidepressant Study Test

Phase 1

Not yet recruiting

Conditions: Effort Based Decision Making
Prosocial Behavior
Apathy

Interventions: Drug: Escitalopram 10mg
Drug: Placebo 10 mg

First Posted Date: 2024-11-20

Last Posted Date: 2024-11-20

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT06696482

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy